The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes

NCT02008682 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

368

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: liraglutide
DRUG: sitagliptin

Sponsor

Novo Nordisk A/S